Skip to main content

Table 3 Antimicrobial resistance of ESBL-producing E. Coli and K. Pneumoniae isolates from community or acquired during hospitalization (number of tested isolates in brackets)

From: High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar

 

Drugs

           
  

AMX

TIC

AMC

CAZ

GEN

TOB

AMK

IMP

NAL

CIP

TMP

Community strains - On admission without prior hospitalization history

E. coli (n = 15)

%

100.0

100.0

100.0

93.3

73.3

80.0

0.0

0.0

86.7

60.0

93.3

K.Pneumoniae (n = 15)

%

100.0

100.0

100.0

86.7

80.0

86.7

0.0

0.0

40.0

33.3

93.3

Hospital-acquired strains - On discharge ESBL-PE negative on admission

E. coli (n = 19)

%

100.0

100.0

100.0

100.0

94.7

100.0

0.0

0.0

94.7

78.9

89.5

K.Pneumoniae (n= 39)

%

100.0

100.0

100.0

79.4

89.7

89.7

0.0

0.0

46.1

35.8

100.0

  1. AMX:Amoxicillin, TIC:Ticarcillin, AMC: Amoxicillin+Clavulanic Acid, CAZ: Ceftazidime, GEN: Gentamicin, TOB:Tobramycin, AMK: Amikacin, IMP: Imipenem, NAL: Nalidixic Acid, CIP: Ciprofloxacin, TMP: Trimethoprim/Sulfamethoxazole.